Menu
Search
|

Menu

Close
X

ICAD Inc ICAD.OQ (NASDAQ Stock Exchange Capital Market)

2.90 USD
+0.36 (+14.17%)
As of 1:49 PM EST
chart
Previous Close 2.54
Open 2.52
Volume 13,787
3m Avg Volume 7,835
Today’s High 2.90
Today’s Low 2.51
52 Week High 4.07
52 Week Low 2.50
Shares Outstanding (mil) 16.86
Market Capitalization (mil) 42.83
Forward P/E 11.58
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY18
12
FY17
28
FY16
26
FY15
42
EPS (USD)
FY18
-0.259
FY17
0.289
FY16
-0.633
FY15
-2.069
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
11.58
10.66
Price to Sales (TTM)
vs sector
1.56
254.80
Price to Book (MRQ)
vs sector
3.92
1.95
Price to Cash Flow (TTM)
vs sector
9.20
14.31
Total Debt to Equity (MRQ)
vs sector
56.27
16.13
LT Debt to Equity (MRQ)
vs sector
50.10
8.32
Return on Investment (TTM)
vs sector
17.23
18.05
Return on Equity (TTM)
vs sector
20.58
19.43

EXECUTIVE LEADERSHIP

Michael Klein
Director, Since 2018
Salary: --
Bonus: --
Richard Christopher
Chief Financial Officer, Executive Vice President, Since 2016
Salary: --
Bonus: --
Stacey Stevens
Senior Vice President - Marketing and Strategy, Since 2006
Salary: $270,000.00
Bonus: --
Jonathan Go
Senior Vice President - Research and Development, Since 2006
Salary: $255,000.00
Bonus: --
R. Scott Areglado
Vice President, Corporate Controller, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Technology
Industry: Computer Hardware
Address:

98 Spit Brook Rd Ste 100
NASHUA   NH   03062-5737

Phone: +1603.8825200

iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. It develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.

SPONSORED STORIES